Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Atractylodin
Cat. No.:
OB0225LY-0261
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Atractylodin has high lipase inhibitory activity, anti-inflammatory and immunomodulatory effects.
Synonym:
Atractydin; 55290-63-6; Atractylodin; 55290-63-6; 2-[(1E-,7E)-nona-1,7-dien-3,5-diynyl]furan; Atractydin; V73E8B6UAC; (E,E)-2-(1,7-Nonadiene-3,5-diynyl)furan; FuraN, 2-(1,7-nonadiene-3,5-diynyl)-, (E,E)-; 2-((1E-,7E)-Nona-1,7-dien-3,5-diyn-1-yl)furan-1-yl)furan; 97235-99-9; 2-((1E-,7E)-nona-1,7-dien-3,5-diynyl)furan; FuraN, 2-[(1E-,7E)-1,7-nonadiene-3,5-diyn-1-yl]-
CAS No.:
55290-63-6
Compound CID:
5321047
Formula:
C13H10O
Formula Weight:
182.22
Specification
Relative Density:
1.056 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Atractylodin plays an important role in the study of anti-inflammatory mechanisms.
Library Information
Targets:
Lipase
Pathways:
Metabolism
Plate Number:
AOCL-4
Plate Location:
c7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
6 mg/mL; 32.93 mM
Water Max Solubility:
<0.1 mg/mL (insoluble)
